Fusion Pharmaceuticals Inc. General and Administrative Expense
Fusion Pharmaceuticals Inc. reported General and Administrative Expense of $14.55 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GeneralAndAdministrativeExpense · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. general and administrative expense for the quarter ending 2024-03-31 was $14.55M, a 61.54% increase year-over-year.
- Fusion Pharmaceuticals Inc. general and administrative expense for the quarter ending 2023-12-31 was $7.63M, a 9.76% increase year-over-year.
- Fusion Pharmaceuticals Inc. general and administrative expense for the quarter ending 2023-09-30 was $6.81M, a 8.22% decline year-over-year.
- Fusion Pharmaceuticals Inc. general and administrative expense for the quarter ending 2023-06-30 was $7.75M, a 0.36% decline year-over-year.
- Fusion Pharmaceuticals Inc. general and administrative expense for fiscal 2023 was $31.20M, a 1.95% increase from fiscal 2022.
- Fusion Pharmaceuticals Inc. general and administrative expense for fiscal 2022 was $30.60M, a 12.92% increase from fiscal 2021.
- Fusion Pharmaceuticals Inc. general and administrative expense for fiscal 2021 was $27.10M, a 30.63% increase from fiscal 2020.
- Fusion Pharmaceuticals Inc. general and administrative expense for fiscal 2020 was $20.74M, a 173.38% increase from fiscal 2019.
| Period end | General and Administrative Expense 3 month | General and Administrative Expense 6 month | General and Administrative Expense 9 month | General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $14.55M 10-Q · filed 2024-05-07 | $22.18M derived: sum of 2 quarters · filed 2024-05-07 | $28.99M derived: sum of 3 quarters · filed 2024-05-07 | $36.74M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $7.63M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $14.44M derived: sum of 2 quarters · filed 2024-03-20 | $22.19M derived: sum of 3 quarters · filed 2024-03-20 | $31.20M 10-K · filed 2024-03-20 |
| 2023-09-30 | $6.81M 10-Q · filed 2023-11-07 | $14.56M derived: sum of 2 quarters · filed 2023-11-07 | $23.57M 10-Q · filed 2023-11-07 | $30.52M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $7.75M 10-Q · filed 2023-08-08 | $16.76M 10-Q · filed 2023-08-08 | $23.71M derived: sum of 3 quarters · filed 2024-05-07 | $31.13M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $9.01M 10-Q · filed 2024-05-07 | $15.96M derived: sum of 2 quarters · filed 2024-05-07 | $23.38M derived: sum of 3 quarters · filed 2024-05-07 | $31.16M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $14.37M derived: sum of 2 quarters · filed 2024-03-20 | $22.15M derived: sum of 3 quarters · filed 2024-03-20 | $30.60M 10-K · filed 2024-03-20 |
| 2022-09-30 | $7.42M 10-Q · filed 2023-11-07 | $15.20M derived: sum of 2 quarters · filed 2023-11-07 | $23.65M 10-Q · filed 2023-11-07 | $29.99M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $7.78M 10-Q · filed 2023-08-08 | $16.23M 10-Q · filed 2023-08-08 | $22.57M derived: sum of 3 quarters · filed 2023-08-08 | $29.72M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $8.45M 10-Q · filed 2023-05-11 | $14.79M derived: sum of 2 quarters · filed 2023-05-11 | $21.94M derived: sum of 3 quarters · filed 2023-05-11 | $28.58M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $6.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $13.49M derived: sum of 2 quarters · filed 2023-03-16 | $20.13M derived: sum of 3 quarters · filed 2023-03-16 | $27.10M 10-K · filed 2023-03-16 |
| 2021-09-30 | $7.16M 10-Q · filed 2022-11-08 | $13.80M derived: sum of 2 quarters · filed 2022-11-08 | $20.76M 10-Q · filed 2022-11-08 | $27.40M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $6.64M 10-Q · filed 2022-08-09 | $13.61M 10-Q · filed 2022-08-09 | $20.25M derived: sum of 3 quarters · filed 2022-08-09 | $26.04M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $6.96M 10-Q · filed 2022-05-10 | $13.60M derived: sum of 2 quarters · filed 2022-05-10 | $19.39M derived: sum of 3 quarters · filed 2022-05-10 | $23.38M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $6.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $12.43M derived: sum of 2 quarters · filed 2022-03-17 | $16.42M derived: sum of 3 quarters · filed 2022-03-17 | $20.74M 10-K · filed 2022-03-17 |
| 2020-09-30 | $5.79M 10-Q · filed 2021-11-09 | $9.78M derived: sum of 2 quarters · filed 2021-11-09 | $14.11M 10-Q · filed 2021-11-09 | $16.83M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $3.99M 10-Q · filed 2021-08-10 | $8.31M 10-Q · filed 2021-08-10 | $11.04M derived: sum of 3 quarters · filed 2021-08-10 | $12.96M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $4.33M 10-Q · filed 2021-05-11 | $7.05M derived: sum of 2 quarters · filed 2021-05-11 | $8.97M derived: sum of 3 quarters · filed 2021-05-11 | $10.74M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | $2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $4.65M derived: sum of 2 quarters · filed 2021-03-25 | $6.42M derived: sum of 3 quarters · filed 2021-03-25 | $7.59M 10-K · filed 2021-03-25 |
| 2019-09-30 | $1.92M 10-Q · filed 2020-11-10 | $3.69M derived: sum of 2 quarters · filed 2020-11-10 | $4.86M 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $1.77M 10-Q · filed 2020-08-11 | $2.94M 10-Q · filed 2020-08-11 |